NIH-funded research R01 grant

Modeling HbS polymerization in sickle cell disease at the single-cell level

Official title: Modeling oxygen-dependent hemoglobin polymerization in sickle cell disease at the single cell level

Funded at Massachusetts General Hospital · NIH-11394205 · Data updated 2026-11-12

A research project uses computer and lab models to understand how sickle hemoglobin polymerizes inside individual red blood cells, with goal of guiding future treatments for people with sickle cell disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 15, 2025
Project endMay 31, 2029
Funding year2026
Award (this year)$688,820
NIH project number5R01HL178560-02
Project IDNIH-11394205 on NIH RePORTER

Who could benefit from this research

Could help

Patients with sickle cell disease and red blood cells available for single-cell analysis may be involved indirectly through samples.

Less likely to help

Patients whose illness does not involve HbS polymerization or who do not contribute samples may not directly benefit.

What this research studies

This project aims to build a mechanistic, single-cell model of HbS polymerization to explain why different patients and even cells within one patient respond differently to treatment. Researchers will integrate factors like HbS concentration, other hemoglobins, and 2,3-BPG to predict polymerization behavior. The work could help prioritize drug candidates and tailor therapies to individual patients in the future. The study combines advanced measurement methods with computational modeling to link cellular biology to potential clinical outcomes. The goal is to reduce reliance on large, lengthy trials by improving preclinical decision-making and personalizing care."

Why it matters

Potential benefit: If successful, the model could speed up drug development and help clinicians choose the best treatment strategy for each patient.

How similar studies have gone: Previous work has advanced single-cell measurements, but a fully predictive polymerization model in humans remains a novel and unproven approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Higgins, John Matthew — Massachusetts General Hospital
  • Study coordinator: Higgins, John Matthew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.